Pith. sign in

REVIEW 2 cited by

PharmaGPT: Domain-Specific Large Language Models for Bio-Pharmaceutical and Chemistry

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2406.18045 v3 pith:N4UROPUL submitted 2024-06-26 cs.CL cs.AI

classification cs.CLcs.AI
keywords llmslanguagemodelsbio-pharmaceuticallargepharmagptspecializedareas
verification ladder T0 review T1 audit T2 compute T3 formal
0 comments
read the original abstract

Large language models (LLMs) have revolutionized Natural Language Processing (NLP) by minimizing the need for complex feature engineering. However, the application of LLMs in specialized domains like biopharmaceuticals and chemistry remains largely unexplored. These fields are characterized by intricate terminologies, specialized knowledge, and a high demand for precision areas where general purpose LLMs often fall short. In this study, we introduce PharmaGPT, a suite of domain specilized LLMs with 13 billion and 70 billion parameters, specifically trained on a comprehensive corpus tailored to the Bio-Pharmaceutical and Chemical domains. Our evaluation shows that PharmaGPT surpasses existing general models on specific-domain benchmarks such as NAPLEX, demonstrating its exceptional capability in domain-specific tasks. Remarkably, this performance is achieved with a model that has only a fraction, sometimes just one-tenth-of the parameters of general-purpose large models. This advancement establishes a new benchmark for LLMs in the bio-pharmaceutical and chemical fields, addressing the existing gap in specialized language modeling. It also suggests a promising path for enhanced research and development, paving the way for more precise and effective NLP applications in these areas.

Discussion (0). Sign in to comment.

Forward citations

Cited by 2 Pith papers

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score. Full citation record

  1. A Japanese Language Model and Three New Evaluation Benchmarks for Pharmaceutical NLP

    cs.CL 2025-05 conditional novelty 6.0 of 10

    A continually pretrained 7B Japanese pharmaceutical LLM outperforms open medical models on new Japanese pharma benchmarks, while all models, including GPT-4o, fail at cross-sentence consistency checks.

  2. BioPars: A Pretrained Biomedical Large Language Model for Persian Biomedical Text Mining

    cs.CL 2025-06 reject novelty 3.0 of 10

    A proposed Persian biomedical LLM, BioPars, is evaluated on medical QA datasets and reported to beat GPT-4 on a self-built Persian QA benchmark, but the training setup is not described.

Pith tools